Algonist Biotechnologies Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Algonist Biotechnologies General Information
Description
Operator of a therapeutic company intended to develop novel non-opioid drugs against chronic pain and neuropathic pain. The company specializes in the development of oral small-molecule therapeutics to treat inflammatory and chronic pain, with drugs that improve efficacy over current treatment options, and without the serious side effects of drugs, enabling patients to get chronic pain relief without damaging neurons in the peripheral and central nervous systems.
Contact Information
Website
www.algonist.comCorporate Office
- Karl-Farkas-Gasse 22
- Vienna, 1030
- Austria
Corporate Office
- Karl-Farkas-Gasse 22
- Vienna, 1030
- Austria
Algonist Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Jul-2022 | Completed | Pre-Clinical Trials | |||
| 1. Angel (individual) | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Algonist Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Algonist Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Algonist Biotechnologies Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARAX Capital Partners | Venture Capital | Minority | ||
| Kinled Holding | Family Office | Minority | ||
| Angel (individual) | Minority |
Algonist Biotechnologies FAQs
-
When was Algonist Biotechnologies founded?
Algonist Biotechnologies was founded in 2020.
-
Where is Algonist Biotechnologies headquartered?
Algonist Biotechnologies is headquartered in Vienna, Austria.
-
What is the size of Algonist Biotechnologies?
Algonist Biotechnologies has 3 total employees.
-
What industry is Algonist Biotechnologies in?
Algonist Biotechnologies’s primary industry is Drug Discovery.
-
Is Algonist Biotechnologies a private or public company?
Algonist Biotechnologies is a Private company.
-
What is Algonist Biotechnologies’s current revenue?
The current revenue for Algonist Biotechnologies is .
-
Who are Algonist Biotechnologies’s investors?
ARAX Capital Partners, Kinled Holding, and have invested in Algonist Biotechnologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
